Vivimed Labs P/E Ratio
Vivimed Labs (VIVIMEDLAB) P/E ratio is not applicable — EPS (TTM) ₹-3.85, 5 consecutive loss quarters. See Healthcare peers with valid P/E ratios below.
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
Company has been reporting losses for 5 consecutive quarters. P/E ratio cannot be calculated for loss-making companies.
Consecutive Loss Quarters: 5
Current EPS: ₹-3.85
Recent Quarterly Performance
| Quarter | EPS (₹) | Net Profit (₹ Cr) | Status |
|---|---|---|---|
| Sept 2025 | -0.88 | -7 | Loss |
| Mar 2025 | -0.68 | -6 | Loss |
| Jun 2025 | -0.66 | -6 | Loss |
| Dec 2025 | -2.00 | -17 | Loss |
| Sept 2024 | -0.62 | -5 | Loss |
| Mar 2024 | 0.63 | 5 | Profit |
| Jun 2024 | -1.84 | -15 | Loss |
| Dec 2024 | -0.72 | -6 | Loss |
Healthcare Peers with Valid P/E Ratios — VIVIMEDLAB Comparison
Healthcare sector average P/E 52.75, median 29.65 — VIVIMEDLAB excluded (negative EPS).
Sector Average PE
52.75
Sector Median PE
29.65
Lowest PE
2.86
Profitable Companies
195
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Sunrest Lifescience | SUNREST | 3.64 | ₹29 | Low |
| Phaarmasia | PHRMASI | 4.06 | ₹68 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.67 | ₹7,432 | Low |
| Shelter Pharma | SHELTER | 5.45 | ₹48 | Low |
| Mono Pharmacare | MONOPHARMA | 6.51 | ₹20 | Low |
| Amwill Health Care | AMWILL | 7.33 | ₹78 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹71 | Low |
| Brooks Laboratories | BROOKS | 7.95 | ₹199 | Low |
| Royal Sense | ROYAL | 8.08 | ₹62 | Low |
Related Analysis
- For live price, revenue and the complete fundamental profile, see VIVIMEDLAB share price.
- Browse VIVIMEDLAB cash flow statement for revenue, profit, balance sheet and cash flow data.
- Analyse VIVIMEDLAB shareholding pattern to track promoter, FII and institutional holdings.